Developmental toxicity of perfluorononanoic acid in mice

Reproductive Toxicology

Volumn 51, Issue , 2015, Pages 133-144

  Das, Kaberi P ^a   Grey, Brian E ^a   Rosen, Mitchell B ^b   Wood, Carmen R ^a   Tatum Gibbs, Katoria R ^a   Zehr, R Daniel ^c   Strynar, Mark J ^d   Lindstrom, Andrew B ^d   Lau, Christopher ^a  

^a Toxicity Assessment Division   (United States)

^b Integrated Systems Toxicology Division   (United States)

^c National Health and Environmental Effects Research Laboratory   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

CD 1 mice; Developmental toxicity; Gene expression; Perfluorononanoic acid

Indexed keywords

PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; FLUOROCARBON; TRANSCRIPTOME;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; FEMALE; FETAL WELL BEING; FETUS; FETUS WEIGHT; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; GESTATION PERIOD; HEPATOMEGALY; HISTOPATHOLOGY; LIVER WEIGHT; MALE; MOUSE; NEWBORN; NEWBORN DEATH; NONHUMAN; PERINATAL PERIOD; PREGNANCY OUTCOME; PROGENY; PUBERTY; SURVIVAL; VISUAL SYSTEM FUNCTION; ANIMAL; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED; DRUG EFFECTS; FETOMATERNAL TRANSFUSION; GENETICS; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE;

MUS; RODENTIA;

ANIMALS; BODY WEIGHT; FEMALE; FLUOROCARBONS; LIVER; MATERNAL-FETAL EXCHANGE; MICE; ORGAN SIZE; PPAR ALPHA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TRANSCRIPTOME;

EID: 84922792837     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2014.12.012     Document Type: Article

References (85)

1. Kissa E. Fluorinated surfactants and repellents 2001, Marcel Dekker, New York. 2nd ed.
2. Giesy J.P., Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 2001, 35:1339-1342.
3. Houde M., Martin J.W., Letcher R.J., Solomon K.R., Muir D.C. Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 2006, 40:3463-3473.
4. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007, 99:366-394.
5. Kato K., Wong L.Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. Environ Sci Technol 2011, 45:8037-8045.
6. Gewurtz S.B., Backus S.M., De Silva A.O., Ahrens L., Armellin A., Evans M., et al. Perfluoroalkyl acids in the Canadian environment: multi-media assessment of current status and trends. Environ Int 2013, 59:183-200.
7. Houde M., De Silva A.O., Muir D.C., Letcher R.J. Monitoring of perfluorinated compounds in aquatic biota: an updated review. Environ Sci Technol 2011, 45:7962-7973.
8. Lau C., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 2004, 198:231-241.
9. Giesy J.P., Naile J.E., Khim J.S., Jones P.D., Newsted J.L. Aquatic toxicology of perfluorinated chemicals. Rev Environ Contam Toxicol 2010, 202:1-52.
10. Lau C. Perfluorinated compounds. Molecular clinical and environmental toxicology, vol. 3: Environmental toxicology 2012, 47-86. Birkhäuser-Verlag, Basel, Switzerland.
11. Apelberg B.J., Witter F.R., Herbstman J.B., Calafat A.M., Halden R.U., Needham L.L., et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 2007, 115:1670-1676.
12. Fei C., McLaughlin J.K., Tarone R.E., Olsen J. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol 2008, 168:66-72.
13. Fei C., McLaughlin J.K., Lipworth L., Olsen J. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 2009, 24:1200-1205.
14. Washino N., Saijo Y., Sasaki S., Kato S., Ban S., Konishi K., et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 2009, 117:660-667.
15. Lopez-Espinosa M.J., Fletcher T., Armstrong B., Genser B., Dhatariya K., Mondal D., et al. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol 2011, 45:8160-8166.
16. Hoffman K., Webster T.F., Weisskopf M.G., Weinberg J., Vieira V.M. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. Environ Health Perspect 2010, 118:1762-1767.
17. Vested A., Ramlau-Hansen C.H., Olsen S.F., Bonde J.P., Kristensen S.L., Halldorsson T.I., et al. Associations of in utero exposure to perfluorinated alkyl acids with human semen quality and reproductive hormones in adult men. Environ Health Perspect 2013, 121:453-458.
18. Kristensen S.L., Ramlau-Hansen C.H., Ernst E., Olsen S.F., Bonde J.P., Vested A., et al. Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction. Hum Reprod 2013, 28:3337-3348.
19. Steenland K., Tinker S., Shankar A., Ducatman A. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect 2010, 118:229-233.
20. Nelson J.W., Hatch E.E., Webster T.F. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general US population. Environ Health Perspect 2010, 118:197-202.
21. Melzer D., Rice N., Depledge M.H., Henley W.E., Galloway T.S. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the US National Health and Nutrition Examination Survey. Environ Health Perspect 2010, 118:686-692.
22. Knox S.S., Jackson T., Frisbee S.J., Javins B., Ducatman A.M. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J Toxicol Sci 2011, 36:403-410.
23. Grandjean P. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. J Am Med Assoc 2012, 307:391-397.
24. Granum B., Haug L.S., Namork E., Stolevik S.B., Thomsen C., Aaberge I.S., et al. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol 2013, 10:373-379.
25. Stein C.R., Savitz D.A. Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age. Environ Health Perspect 2011, 119:1466-1471.
26. Stein C.R., Savitz D.A., Bellinger D.C. Perfluorooctanoate and neuropsychological outcomes in children. Epidemiology 2013, 24:590-599.
27. Vesterholm Jensen D., Christensen J., Virtanen H.E., Skakkebaek N.E., Main K.M., Toppari J., et al. No association between exposure to perfluorinated compounds and congenital cryptorchidism: a nested case-control study among 215 boys from Denmark and Finland. Reproduction 2014, 147:411-417.
28. Whitworth K.W., Haug L.S., Baird D.D., Becher G., Hoppin J.A., Skjaerven R., et al. Perfluorinated compounds and subfecundity in pregnant women. Epidemiology 2012, 23:257-263.
29. Olsen G.W., Ehresman D.J., Buehrer B.D., Gibson B.A., Butenhoff J.L., Zobel L.R. Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of perfluoroalkyl manufacturing facilities. J Occup Environ Med 2012, 54:974-983.
30. Raymer J.H., Michael L.C., Studabaker W.B., Olsen G.W., Sloan C.S., Wilcosky T., et al. Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements. Reprod Toxicol 2012, 33:419-427.
31. Andersen C.S., Fei C.Y., Gamborg M., Nohr E.A., Sorensen T.I.A., Olsen J. Prenatal exposures to perfluorinated chemicals and anthropometry at 7 years of age. Am J Epidemiol 2013, 178:921-927.
32. DeWitt J.C., Shnyra A., Badr M.Z., Loveless S.E., Hoban D., Frame S.R., et al. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 2009, 39:76-94.
33. Tatum-Gibbs K., Wambaugh J.F., Das K.P., Zehr R.D., Strynar M.J., Lindstrom A.B., et al. Comparative pharmacokinetics of perfluorononanoic acid in rat and mouse. Toxicology 2011, 281:48-55.
34. Lou I.C., Wambaugh J.F., Lau C., Hanson R.G., Lindstrom A.B., Strynar M.J., et al. Modeling single and repeated dose pharmacokinetics of PFOA in mice. Toxicol Sci 2009, 107:331-341.
35. Wolf C.J., Schmid J.E., Lau C., Abbott B.D. Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARalpha) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds. Reprod Toxicol 2012, 33:546-551.
36. Kinney L.A., Chromey N.C., Kennedy G.L. Acute inhalation toxicity of ammonium perfluorononanoate. Food Chem Toxicol 1989, 27:465-468.
37. Fang X.M., Zou S.S., Zhao Y.Y., Cui R.N., Zhang W., Hu J.Y., et al. Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor alpha expression by releasing cytokines. Arch Toxicol 2012, 86:1515-1525.
38. Fang X.M., Gao G.Z., Xue H.Y., Zhang X.T., Wang H.C. In vitro and in vivo studies of the toxic effects of perfluorononanoic acid on rat hepatocytes and Kupffer cells. Environ Toxicol Pharmacol 2012, 34:484-494.
39. Fang X.M., Gao G.Z., Xue H.Y., Zhang X.T., Wang H.C. Exposure of perfluorononanoic acid suppresses the hepatic insulin signal pathway and increases serum glucose in rats. Toxicology 2012, 294:109-115.
40. Zhang W., Liu Y., Zhang H.X., Dai J.Y. Proteomic analysis of male zebrafish livers chronically exposed to perfluorononanoic acid. Environ Int 2012, 42:20-30.
41. Zhang W., Zhang Y.T., Zhang H.X., Wang J.S., Cui R.N., Dai J.Y. Sex differences in transcriptional expression of FABPs in zebrafish liver after chronic perfluorononanoic acid exposure. Environ Sci Technol 2012, 46:5175-5182.
42. Liu Y., Wang J.S., Fang X.M., Zhang H.X., Dai J.Y. The thyroid-disrupting effects of long-term perfluorononanoate exposure on zebrafish (Danio rerio). Ecotoxicology 2011, 20:47-55.
43. Fang X., Zhang L., Feng Y., Zhao Y., Dai J. Immunotoxic effects of perfluorononanoic acid on BALB/c mice. Toxicol Sci 2008, 105:312-321.
44. Fang X., Feng Y., Wang J., Dai J. Perfluorononanoic acid-induced apoptosis in rat spleen involves oxidative stress and the activation of caspase-independent death pathway. Toxicology 2010, 267:54-59.
45. Rockwell C.E., Turley A.E., Cheng X., Fields P.E., Klaassen C.D. Acute immunotoxic effects of perfluorononanoic acid (PFNA) in C57BL/6 mice. Clin Exp Pharmacol 2013, S4:002.
46. Feng Y.X., Shi Z.M., Fang X.M., Xu M.Q., Dai J.Y. Perfluorononanoic acid induces apoptosis involving the Fas death receptor signaling pathway in rat testis. Toxicol Lett 2009, 190:224-230.
47. Feng Y.X., Fang X.M., Shi Z.M., Xu M.Q., Dai J.Y. Effects of PFNA exposure on expression of junction-associated molecules and secretory function in rat Sertoli cells. Reprod Toxicol 2010, 30:429-437.
48. Stump D.G., Holson J.F., Murphy S.R., Farr C.H., Schmit B., Shinohara M. An oral two-generation reproductive toxicity study of S-111-S-WB in rats. Reprod Toxicol 2008, 25:7-20.
49. Wolf C.J., Zehr R.D., Schmid J.E., Lau C., Abbott B.D. Developmental effects of perfluorononanoic acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha. PPAR Res 2010, 2010. 11 pages [Article ID 282896].
50. Lau C., Thibodeaux J.R., Hanson R.G., Narotsky M.G., Rogers J.M., Lindstrom A.B., et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 2006, 90:510-518.
51. Narotsky M.G., Kavlock R.J. In vivo assessment of prenatal developmental toxicity in rodents. Curr Protoc Toxicol 2003, [ed. Mahin D Maines. Chapter 13: Unit13 5].
52. Narotsky M.G., Rogers J.M. Examination of the axial skeleton of fetal rodents. Developmental biology protocols 2000, vol. I:139-150. Humana, New Jersey.
53. Wilson J.G. Methods for administering agents and detecting malformations in experimental animals. Teratology: principles and techniques 1965, 262-277. Univ Chicago Press, Chicago. J.G. Wilson, J. Warkany (Eds.).
54. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the US population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 2007, 115:1596-1602.
55. -δδCT Method. Methods 2001, 25:402-408.
56. Barnes D.G., Daston G.P., Evans J.S., Jarabek A.M., Kavlock R.J., Kimmel C.A., et al. Benchmark dose workshop: criteria for use of a benchmark dose to estimate a reference dose. Regul Toxicol Pharmacol 1995, 21:296-306.
57. Crump K.S. A new method for determining allowable daily intakes. Fundam Appl Toxicol 1984, 4:854-871.
58. Allen B.C., Kavlock R.J., Kimmel C.A., Faustman E.M. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam Appl Toxicol 1994, 23:487-495.
59. Anderson S.P., Dunn C., Laughter A., Yoon L., Swanson C., Stulnig T.M., et al. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver. Mol Pharmacol 2004, 66:1440-1452.
60. Anderson S.P., Howroyd P., Liu J., Qian X., Bahnemann R., Swanson C., Kwak M.K., Kensler T.W., Corton J.C. The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J Biol Chem 2004, 279:52390-52398.
61. Cheng X., Klaassen C.D. Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors. Toxicol Sci 2008, 106:29-36.
62. Rosen M.B., Schmid J.E., Das K.P., Wood C.R., Zehr R.D., Lau C. Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid. Reprod Toxicol 2009, 27:278-288.
63. Rosen M.B., Lee J.S., Ren H., Vallanat B., Liu J., Waalkes M.P., et al. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. Toxicol Sci 2008, 103:46-56.
64. Xie W., Barwick J.L., Downes M., Blumberg B., Simon C.M., Nelson M.C., et al. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 2000, 406:435-439.
65. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., Richards J.H., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I. Maternal and prenatal evaluations. Toxicol Sci 2003, 74:369-381.
66. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II. Postnatal evaluation. Toxicol Sci 2003, 74:382-392.
67. Das K.P., Grey B.E., Zehr R.D., Wood C.R., Butenhoff J.L., Chang S.C., et al. Effects of perfluorobutyrate exposure during pregnancy in the mouse. Toxicol Sci 2008, 105:173-181.
68. Fenton S.E., Reiner J.L., Nakayama S.F., Delinsky A.D., Stanko J.P., Hines E.P., et al. Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups. Reprod Toxicol 2009, 27:365-372.
69. Karrman A., Ericson I., van Bavel B., Darnerud P.O., Aune M., Glynn A., et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 2007, 115:226-230.
70. Capriotti A.L., Cavaliere C., Cavazzini A., Foglia P., Lagana A., Piovesana S., et al. High performance liquid chromatography tandem mass spectrometry determination of perfluorinated acids in cow milk. J Chromatogr A 2013, 1319:72-79.
71. Mondal D., Weldon R.H., Armstrong B.G., Gibson L.J., Lopez-Espinosa M.J., Shin H.M., et al. Breastfeeding: a potential excretion route for mothers and implications for infant exposure to perfluoroalkyl acids. Environ Health Perspect 2014, 122:187-192.
72. Rosen M.B., Das K.P., Wood C.R., Wolf C.J., Abbott B.D., Lau C. Evaluation of perfluoroalkyl acid activity using primary mouse and human hepatocytes. Toxicology 2013, 308:129-137.
73. Grasty R.C., Grey B.E., Lau C.S., Rogers J.M. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B 2003, 68:465-471.
74. Luebker D.J., York R.G., Hansen K.J., Moore J.A., Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 2005, 215:149-169.
75. Yahia D., Tsukuba C., Yoshida M., Sato I., Tsuda S. Neonatal death of mice treated with perfluorooctane sulfonate. J Toxicol Sci 2008, 33:219-226.
76. Yahia D., Abd El-Nasser M., Abedel-Latif M., Tsukuba C., Yoshida M., Sato I., et al. Effects of perfluorooctanoic acid (PFOA) exposure to pregnant mice on reproduction. J Toxicol Sci 2010, 35:527-533.
77. Rosen M.B., Abbott B.D., Wolf D.C., Corton J.C., Wood C.R., Schmid J.E., et al. Gene profiling in the livers of wild-type and PPAR{alpha}-null mice exposed to perfluorooctanoic acid (PFOA). Toxicol Pathol 2008, 36:592-607.
78. Rosen M.B., Schmid J.R., Corton J.C., Zehr R.D., Das K.P., Abbott B.D., et al. Gene expression profiling in wild-type and PPARalpha-null mice exposed to perfluorooctane sulfonate reveals pparalpha-independent effects. PPAR Res 2010, 23. [Article ID 794739].
79. Oshida K., Vasani N., Carswell G., Ward W., Fostel J., Shah I., et al. Identification of novel chemical and genetic effectors of the nuclear receptor peroxisome proliferator-activated receptor-alpha (PPAR-a). PLoS ONE 2014, [in press].
80. Escher P., Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 2000, 448:121-138.
81. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999, 20:649-688.
82. Patsouris D., Mandard S., Voshol P.J., Escher P., Tan N.S., Havekes L.M., et al. PPARalpha governs glycerol metabolism. J Clin Invest 2004, 114:94-103.
83. Xie W., Barwick J.L., Simon C.M., Pierce A.M., Safe S., Blumberg B., et al. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 2000, 14:3014-3023.
84. Rosen M.B., Thibodeaux J.R., Wood C.R., Zehr R.D., Schmid J.E., Lau C. Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. Toxicology 2007, 239:15-33.
85. Iwai H., Hoberman A.M. Oral (gavage) combined developmental and perinatal/postnatal reproduction toxicity study of ammonium salt of perfluorinated hexanoic acid in mice. Int J Toxicol 2014, 33:219-237.